GATEWAY FOR CANCER RESEARCH

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

PETER STEELE

Phone

8882212873

Tax Period

2024-07-01 to 2025-06-30

GATEWAY FOR CANCER RESEARCH, founded in 1991, is a community nonprofit in the Medical Research sector that reported $9.7M in total revenue in fiscal year 2024. Expenses of $11.2M exceeded revenue, resulting in a 16% operating deficit.

Mission

TO ACCELERATE PRACTICE-CHANGING DISCOVERIES IN CANCER CARE BY HARNESSING THE UNRELENTING PASSION OF THE RESEARCH COMMUNITY AND EMPOWERING PATIENTS TO TRIUMPH OVER THEIR DISEASE.

Program Service Accomplishments

Program 1

Expenses: $6,270,031

GATEWAY FOR CANCER RESEARCH, A NON-PROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1991 TO PROMOTE RESEARCH THAT MORE TRADITIONAL CANCER RESEARCH INSTITUTIONS MAY NOT FUND. GATEWAY IS DEDICATED TO ADVANCING INNOVATIONS IN THE SCIENTIFIC COMMUNITY AND SPEEDING THEM TO THE CANCER PATIENT'S BEDSIDE. THE WORK OF GATEWAY IS ABOUT GIVING CANCER PATIENTS THE ABILITY TO LIVE LONGER, MORE FULFILLING AND HEALTHIER LIVES.100% OF PUBLIC CONTRIBUTIONS RECEIVED ARE APPLIED DIRECTLY TO SUPPORT CANCER RESEARCH. OUR RESEARCH AND GRANTS COMMITTEE APPLIES STRINGENT GUIDELINES FOR REVIEWING EACH GRANT APPLICATION, RECOMMENDING TO THE BOARD OF DIRECTORS ONLY THOSE THAT ARE IN KEEPING WITH THE FOUNDATION'S MISSION. GATEWAY FOR CANCER RESEARCH RECEIVES FUNDING FROM A PRIVATE ENTITY UNDERWRITING ADMINISTRATIVE AND FUNDRAISING COSTS. THIS ALLOWS DONOR DOLLARS TO BE DIRECTED TO PATIENT-CENTERED RESEARCH. GATEWAY FOR CANCER RESEARCH IS CURRENTLY FUNDING 64 STUDIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $12,384,614

Program Service Revenue $0

Investment Income $967,331

Other Revenue $-3,698,656

TOTAL REVENUE $9,653,289

Expense Breakdown

Grants Paid $5,812,285

Salaries & Benefits $1,671,649

Fundraising Expenses $1,518,763

Program Expenses $6,270,031

Other Expenses $3,706,978

TOTAL EXPENSES $11,190,912

Year-over-Year Comparison

	2024	2023	Change
Revenue	$9,653,289	$9,383,526	+0.0%
Expenses	$11,190,912	$8,628,310	+0.3%
Net Income	$-1,537,623	$755,216	-3.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$490,825

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
FRED DEGRANDIS	SECRETARY	0.30	Officer Director	$0	$0	$0
TIMOTHY FLANIGAN	ASSISTANT SECRETARY	0.30	Director	$0	$0	$0
EMANUEL PETRICOIN PHD	DIRECTOR	0.30	Director	$0	$0	$0
SATISH TADIKONDA PHD	DIRECTOR	0.30	Director	$0	$0	$0
STACIE J STEPHENSON	VICE CHAIR	0.30	Officer Director	$0	$0	$0
TONY FESTA	TREASURER	0.30	Officer Director	$0	$0	$0
MARY LOU SMITH	DIRECTOR	0.30	Director	$0	$0	$0
RICHARD J STEPHENSON	CHAIRMAN	0.30	Officer Director	$0	$0	$0
DENIZ RAZON	DIRECTOR	0.30	Director	$0	$0	$0
JOE CALTABIANO	DIRECTOR	0.30	Director	$0	$0	$0
TAWNYA BOND	DIRECTOR	0.30	Director	$0	$0	$0
EDWIN ROBERSON	DIRECTOR	0.30	Director	$0	$0	$0
MICHAEL JESSUP	INTERIM CEO (STARTING MAY 2025)	40.00	Officer	$0	$0	$0
DELORA SENFT	CHIEF OPERATING OFFICER	40.00	Officer	$160,295	$23,229	$183,524
NATALIE STEWART	PRESIDENT & CEO (THROUGH MAY 2025)	40.00	Officer	$281,250	$26,051	$307,301
MARIA CONSUELO AROZ	CREATIVE DIRECTOR	40.00	Highest	$107,817	$15,641	$123,458
KARI WATTS	DIRECTOR OF MARKETING	40.00	Highest	$104,832	$19,157	$123,989
HUNTER PATTON-GENTERT	DIRECTOR CLINICAL SCIENCE	40.00	Highest	$138,657	$21,788	$160,445
NATALIA MIHILLI	VP OF DEVELOPMENT	40.00	Highest	$150,034	$23,322	$173,356

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$9,653,289	$11,190,912	$20,272,224	$-1,537,623
2024	$9,383,526	$8,628,310	$21,075,932	$755,216
2023	$10,470,741	$9,525,588	$20,261,940	$945,153
2022	$8,777,254	$8,649,106	$17,585,556	$128,148
2021	$4,888,015	$7,879,868	$18,916,146	$-2,991,853
2020	$5,460,832	$5,555,438	$17,327,076	$-94,606
2019	$5,581,854	$3,170,033	$15,896,617	$2,411,821